{"picks": [{"ticker": "RTX", "thesis": "The White House is hosting RTX CEO Chris Calio and executives from America's largest defense contractors on March 6, 2026 (today) for an urgent summit to accelerate munitions production as U.S. missile interceptor and artillery inventories are being drawn down rapidly by U.S.-Israel strikes on Iran \u2014 a direct mechanism to emergency procurement contracts and multi-year backlog expansion for RTX's Patriot/StormBreaker/Raytheon division. Technically, RTX broke out from a flat-base consolidation pattern at the $206 pivot last week after finding support at its 50-day SMA, with Deutsche Bank raising its price target to $240 from $235 this week on a Buy rating and 22 of 22 technical indicators flashing bullish; the stock has surged 64% over the past year with RSI in healthy mid-50s range. Thesis is invalidated if the White House meeting produces no new procurement commitment language, or if a ceasefire/diplomacy materially reduces U.S.-Iran conflict intensity within 2 weeks.", "take_profit": 232.4, "stop_loss": 187.55, "max_days": 35, "pop": 89, "type": "stock"}, {"ticker": "AVGO", "thesis": "Broadcom reported record Q1 FY2026 results on March 4, 2026 \u2014 revenue $19.31B (+29% YoY), AI revenue $8.4B (+106% YoY) beating its own forecast, with Q2 guidance of $22.0B (+47% YoY) dramatically above the $20.56B Street consensus, and CEO Hock Tan declared line-of-sight to AI chip revenue exceeding $100 billion in 2027 from hyperscaler custom silicon demand (Google TPUs, OpenAI, Meta MTIA); Argus raised price target to $425 from $375, and the board authorized a new $10B buyback. Technically, AVGO broke higher on March 5 with volume 2.5x average (57M vs 23M avg), closing at $332 after a bullish wedge pattern resolved to the upside from the $295-305 demand band, and the stock remains down ~10% YTD offering a re-entry opportunity after the Q1 catalyst confirmation; next earnings not until June 4, giving full runway. Thesis fails if AI infrastructure capex suddenly freezes (a hyperscaler CapEx cut announcement from Google/Microsoft/Meta) or if semiconductor export restrictions are significantly tightened, breaking AVGO below $295 support.", "take_profit": 392.67, "stop_loss": 302.82, "max_days": 40, "pop": 87, "type": "stock"}, {"ticker": "ORCL", "thesis": "Oracle reports Q3 FY2026 earnings on March 10, 2026 (confirmed, 4 days away) with analyst consensus expecting cloud revenue growth of 37-41% in constant currency and 19-21% total revenue growth \u2014 management guided to this range in Q2 with company tracking a $523B remaining performance obligation backlog driven by AI mega-deals with OpenAI (Stargate) and Meta; Oracle beat EPS by 37.8% last quarter and has beaten 3 consecutive quarters, and Mizuho added ORCL as a new March top pick on March 4, 2026 with analyst Siti Panigrahi maintaining Outperform and $400 price target citing AI workflows and Oracle Cloud Infrastructure demand. ORCL is trading at $152-154, down 48% from its $346 September 2025 all-time high, with support near $118-120 (50-day avg ~$172, stock below both MAs creating a mean-reversion setup into a hard catalyst), and the market has aggressively derisked the valuation to ~28x PE \u2014 a beat on cloud ARR growth and RPO expansion could trigger a sharp recovery move. Thesis is invalidated by a Q3 revenue miss combined with RPO growth deceleration or any further Stargate project cancellation/restructuring news before earnings.", "take_profit": 185.75, "stop_loss": 139.31, "max_days": 12, "pop": 86, "type": "stock"}, {"ticker": "PLTR", "thesis": "Palantir is the primary commercial AI platform used by U.S. defense and intelligence agencies, and the Pentagon's January 2026 'AI-first warfighting force' mandate \u2014 backed by $13.4B in FY2026 DoD AI spending \u2014 directly drives AIP (Artificial Intelligence Platform) contract expansion across military branches; Palantir just reported Q4 FY2025 EPS of $0.25 (19% beat vs $0.21 estimate) with revenue $1.41B, and analysts project 30.82% upside with consensus at $186.41 (Rosenblatt Buy rating on March 3, 2026). Technically, PLTR is consolidating at $149-156 with a 52-week range of $66-$207, trading above key moving averages with RSI in healthy mid-50s range and the defense AI narrative at peak intensity due to U.S.-Iran conflict; next earnings not until May 4 giving full swing runway. Thesis is invalidated if Trump's DOJ investigation into Fed Chair Powell triggers a broad market risk-off selloff that crushes high-beta growth, or if Palantir loses a material government contract renewal.", "take_profit": 177.1, "stop_loss": 137.4, "max_days": 38, "pop": 84, "type": "stock"}, {"ticker": "NEM", "thesis": "Gold prices have surged to record highs above $5,000/oz driven by U.S.-Iran geopolitical conflict, de-dollarization capital flows, and rising inflation (3% CPI) that keeps real rates negative \u2014 Newmont, the world's largest gold producer, reported Q4 2025 EPS of $2.52 (vs $2.03 consensus, +24% beat) and revenue of $6.8B (+21% YoY) and is guiding to 5.3M oz gold production in 2026 at $1,680/oz AISC, generating massive free cash flow margins at current spot prices; Sanford Bernstein upgraded NEM from Market Perform to Outperform with a $157 price target on the Friday prior, and Citigroup raised its target to $150 (Buy) with Scotiabank at $152 (Outperform). NEM pulled back ~8% from its $134 all-time high on a TD Securities downgrade (to Hold, $118 PT) and gold profit-taking, providing a mean-reversion entry to ~$119-122 with strong institutional support (Arrowstreet Capital increased position 110%, Invesco +45%, Norges Bank new $919M stake) ahead of an earnings catalyst on April 23. Thesis fails if gold prices break below $4,500/oz (negating the margin expansion thesis) or if Newmont's Ahafo North mine ramp faces material operational disruption.", "take_profit": 141.63, "stop_loss": 102.16, "max_days": 55, "pop": 81, "type": "stock"}, {"ticker": "AVGO", "thesis": "Broadcom reported record Q1 FY2026 revenue of $19.3B (+29% YoY) on March 4, 2026, with AI semiconductor revenue of $8.4B up 106% YoY, beating consensus; Q2 guidance of ~$22B (+47% YoY) and AI revenue guided to $10.7B in Q2 \u2014 a historic acceleration driving a 5%+ after-hours surge with next earnings not until June 3. Technically, AVGO was trading at ~$313 pre-earnings, below both its 50-day MA ($335) and 200-day MA ($318), creating a compressed coil setup; the post-earnings gap-up resolves that compression with an immediate recapture of the 200-day MA as a new support floor. Thesis is invalidated if Q2 AI revenue guidance is revised down due to Anthropic supply-chain disruption (Pentagon ban on Anthropic tools) or if hyperscaler capex freeze signals emerge in the next 7 trading days.", "take_profit": 365.16, "stop_loss": 292.13, "max_days": 12, "pop": 88, "type": "stock"}, {"ticker": "PLTR", "thesis": "Rosenblatt Securities analyst John McPeake raised Palantir's price target to $200 from $150 on March 3, 2026, calling Operation Epic Fury a 'live-fire validation' of PLTR's AIP and Maven Smart System \u2014 the exact platforms now being used in active US-Israeli military operations against Iran \u2014 with a DISA authorization for PFCS Forward secured February 12 extending IL5/IL6 accreditation for defense deployments. Technically, PLTR reversed off $130 support and broke above its upper Bollinger Band on March 2; the stock is now reclaiming the $150 key resistance level after a >20% YTD drawdown that created a deeply oversold base, with the momentum indicator turning positive on February 26. Thesis is invalidated if the US-Iran conflict de-escalates rapidly (ceasefire announced) removing the defense AI urgency premium, or if the Anthropic/Pentagon entanglement expands to restrict PLTR's own federal AI platform contracts.", "take_profit": 180.76, "stop_loss": 140.93, "max_days": 15, "pop": 86, "type": "stock"}, {"ticker": "RTX", "thesis": "RTX signed five up-to-seven-year framework agreements with the US Department of War on February 4, 2026, to dramatically ramp Tomahawk (1,000+ annually), AMRAAM (1,900+), SM-3, and SM-6 (500+) production \u2014 the exact munitions being consumed in Operation Epic Fury \u2014 creating a direct replenishment order mechanism that Morgan Stanley named RTX its Top Pick in Aerospace with a raised price target on January 28, while Citi raised its target to $238 and Baird lifted to $225; next earnings April 28 falls outside the 35-day hold window. Technically, RTX is trading near $209 with a 52-week high of $214.50, MACD turned positive on March 2, the stock is in a confirmed uptrend with the Aroon indicator entering an uptrend pattern, and the RSI at ~57 is in the healthy momentum zone without being overbought \u2014 the stock surged 4.46% on March 2 alone. The thesis is invalidated if a broad ceasefire in the Middle East is announced before April earnings, removing the urgency premium on munitions replenishment contracts, or if the Pentagon's 'Extended Review Period' of defense contractors results in RTX-specific contract suspensions.", "take_profit": 233.88, "stop_loss": 192.11, "max_days": 30, "pop": 83, "type": "stock"}, {"ticker": "XOM", "thesis": "ExxonMobil is the primary beneficiary of the US-Iran conflict-driven oil spike with Brent crude at $84/bbl and threatening further escalation as Iran vowed to retaliate against US strikes; XOM's production hit 40-year highs at 4.7M BOE/day in Q4 2025 led by Permian and Guyana assets with Golden Pass LNG first cargoes expected in early March 2026 \u2014 a fresh production catalyst within the hold window \u2014 while the XLE ETF hit an all-time high of $108.42 with the heaviest institutional inflows into energy in over a decade; analysts at RBC and Wells Fargo raised XOM targets to $150-$160 citing projected $52B in cash flow for 2025-2026. Technically, XOM's momentum indicator crossed above zero on February 27, all moving averages from MA5 to MA200 are on Buy signals, the 50-day MA ($149.49) and 200-day MA ($143.69) are both below current price (~$152), and the MACD is positive; 24 of 26 technical indicators signal bullish with RSI at ~54 \u2014 neutral-to-bullish, not overbought. Thesis is invalidated if Iran-US ceasefire is announced and Brent crude drops below $70, or if the Strait of Hormuz reopens and tanker insurance costs normalize, removing the supply-disruption premium from XOM's valuation.", "take_profit": 164.8, "stop_loss": 136.34, "max_days": 35, "pop": 81, "type": "stock"}, {"ticker": "HWM", "thesis": "Howmet Aerospace reported Q4 2025 EPS of $1.05 (vs $0.97 estimate) on February 12, 2026, raised FY2026 guidance to $4.35-4.55 EPS, guided 15% revenue growth, and has a Investor Day on March 10, 2026 \u2014 a confirmed catalyst within the hold window \u2014 where management will detail the $1B gas turbine business doubling roadmap and the $1.8B Consolidated Aerospace Manufacturing acquisition integration; the company has delivered a 100%+ return over the past 12 months driven by Commercial (+13%), Defense (+20%), and Industrial Gas Turbine (+32%) segment growth with spares rising to 21% of revenue (from 17%), creating high-margin recurring cash flow durability. Technically, HWM recently touched a 52-week high near $263 with 90.46% institutional ownership and the 50-day MA at $216 well below current price; Stratos Wealth Partners increased its stake by 20.3% (to 153,889 shares), BI Asset Management raised its position by 28.3%, and Navellier added 9.6% \u2014 all recent 13F filings confirming sustained demand from smart money with a TIKR valuation model implying ~15% upside to $302. The thesis is invalidated if Boeing or Airbus announce production rate cuts that reduce Howmet's engine component demand, or if the $1.8B CAM acquisition integration reveals unforeseen liabilities at the March 10 Investor Day.", "take_profit": 301.7, "stop_loss": 228.88, "max_days": 55, "pop": 82, "type": "stock"}, {"ticker": "NOC", "thesis": "Operation Epic Fury (Feb 28, 2026) accelerated Pentagon fast-tracking of interceptors and B-21 Raider bomber orders, directly targeting NOC's core programs with a U.S. military posture confirmed 'four to five weeks or longer,' and a Trump defense budget proposal of $1.5T by 2027 providing multi-year backlog expansion on top of NOC's already-record $95.7B backlog. NOC closed at a new all-time high of $768 on March 2 on 2x average volume, above both its 50-DMA (~$680) and 200-DMA (~$600), with no major resistance overhead after the ATH breakout. Thesis is invalidated if a ceasefire or peace accord in Iran is announced before April, or if a supplemental defense budget request is rejected by Congress.", "take_profit": 865.39, "stop_loss": 698.38, "max_days": 35, "pop": 90, "type": "stock"}, {"ticker": "RTX", "thesis": "Raytheon's Tomahawk cruise missiles, AMRAAM air-to-air missiles, and SM-6 interceptors are central to Operation Epic Fury munitions consumption, and RTX boosted production agreements for all three in February 2026 before the conflict began \u2014 creating an exact supply-demand inflection with a $268B record backlog and 2026 EPS guidance of $6.60-$6.80 that analysts view as conservative given the conflict escalation; Morgan Stanley holds an Overweight rating with a $235 target and JPMorgan recently raised its target to $215. RTX reached $211.51 on March 2 (+4.4%), closing above its 50-DMA and 200-DMA; the stock rallied 62% over the prior year and is constructively consolidating below the $212-215 resistance band with an RSI not yet overbought. Thesis is invalidated if RTX closes below $200 (50-DMA support zone) on volume, or if the Iran conflict resolves rapidly with a ceasefire within 2 weeks \u2014 reducing urgency of new munitions orders.", "take_profit": 239.56, "stop_loss": 190.0, "max_days": 55, "pop": 88, "type": "stock"}, {"ticker": "COP", "thesis": "Goldman Sachs added COP to its U.S. Conviction Buy List calling the company 'on the cusp' of a significant re-rating precisely as Brent crude spiked 8-9% on the Strait of Hormuz closure (March 1-2, 2026), and COP's pure-play upstream model \u2014 no refining, no retail \u2014 makes it the most leveraged major to higher crude prices with 2.33-2.36M boepd 2026 production guidance plus a $1B cost-cut plan and Marathon Oil integration adding scale; at $118+ current levels, COP trades at just 14x 2026 EPS with roughly $7 in earnings power at elevated oil. COP hit a new 52-week high of $119.30 on March 3, trading above both the 50-DMA and 200-DMA, with above-average volume confirming the breakout from a 3-month base above prior resistance near $108-110. Thesis fails if Brent crude falls back below $70/barrel on a rapid ceasefire/Hormuz reopening, or if COP provides a negative Q1 production update before May 14 earnings.", "take_profit": 136.3, "stop_loss": 107.85, "max_days": 30, "pop": 85, "type": "stock"}, {"ticker": "NEM", "thesis": "Gold breached $5,300/oz on March 2 as the Hormuz closure triggered simultaneous flight to safety AND inflation re-pricing, and Newmont reported record $7.3B free cash flow for FY2025 (up 150% YoY) with Q4 adjusted EPS of $2.52 vs $1.81 consensus \u2014 Citigroup raised its target to $150, Sanford Bernstein upgraded to Outperform with a $157 target, and Jefferies raised its target to $158 in the past 14 days, all representing 15-25% upside from current levels; NEM's 50-DMA of $116 and 200-DMA of $96 provide massive downside structural support. NEM closed around $128 on March 3, above both moving averages, generating unusual options activity with 67,628 call options purchased March 2 (91% above average daily volume), confirming institutional accumulation ahead of the gold surge \u2014 key resistance is the January 2026 ATH of $134.88, with a clean break toward $150 likely if gold sustains above $5,000. Thesis fails if gold drops sharply below $4,800 on a rapid geopolitical resolution, or if NEM Q1 earnings (April 23) disappoint on AISC cost-creep above $1,800/oz.", "take_profit": 138.67, "stop_loss": 106.67, "max_days": 40, "pop": 83, "type": "stock"}, {"ticker": "LMT", "thesis": "Lockheed Martin's F-35 fighters, PAC-3 MSE interceptors, and precision-guided munitions are directly central to Operation Epic Fury per public Pentagon statements \u2014 LMT received a $24.3B F-35 contract and a landmark 7-year PAC-3 MSE framework agreement boosting annual production from ~600 to 2,000 units/year, with CEO Jim Taiclet referencing 'unprecedented demand' in a January 29, 2026 earnings call that guided 2026 segment operating profit growth >25% YoY and EPS of $29.35-$30.25 \u2014 the Iran conflict makes these already-bullish figures appear conservative; Q1 2026 earnings on April 21 are outside the 12-day momentum hold window, making this a clean catalyst trade. LMT hit an all-time high of $676.70 on March 2 and is retesting that level, trading above both its 50-DMA (~$590) and 200-DMA (~$510), with a constructive bull flag forming on the daily chart after a 35%+ YTD move. Thesis fails if LMT's current guidance implies no Iran upside (already baked in) OR if a ceasefire reverses the geopolitical premium before April 21 earnings.", "take_profit": 747.96, "stop_loss": 621.07, "max_days": 12, "pop": 81, "type": "stock"}], "posted_at": "2026-03-06T08:32:55.584058", "count": 15}